*Some Market data delayed by 15 mins.

Kamada Ltd

Symbol: KMDA (NASDAQ)
6.83 ▼ (-1.66%) -0.115

Company Description:
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Key Stats
  • Today's Open: $6.79
  • Today's High: $6.915
  • Today's Low: $6.775
  • Today's Volume: 37.87K
  • Yesterday Close: $6.94
  • Yesterday High: $7
  • Yesterday Low: $6.85
  • Yesterday Volume: 59.53K
  • Last Min Volume: 474
  • Last Min High: $6.84
  • Last Min Low: $6.825
  • Last Min VWAP: $6.83146
Company Profile
  • Name: Kamada Ltd
  • Website: https://www.kamada.com
  • Listed Date: 2013-05-31
  • Location: ,
  • Market Status: Active
  • CIK Number: 0001567529
  • SIC Code:
  • SIC description:
  • Market Cap: $399.08M
  • Round Lot: 100
  • Outstanding Shares: 57.51M
  • Asset Type: CS
RECENT FILINGS FOR KMDA
Filing Date Filing Type Format
2025-09-02 6-K View
2025-08-13 6-K View
2025-08-11 6-K View
2025-08-06 6-K View
2025-06-17 6-K View
2025-06-05 SCHEDULE 13G/A View
2025-05-14 6-K View
2025-05-07 6-K View
2025-05-05 6-K View
2025-03-24 6-K View
2025-03-19 6-K View
2025-03-05 SCHEDULE 13G/A View
2025-03-05 20-F View
2025-03-05 6-K View
2025-02-26 6-K View
2025-01-22 6-K View
2025-01-08 6-K View
2024-12-11 6-K View
2024-11-14 SC 13G/A View
2024-11-13 6-K View
Latest News on KMDA

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.